Poland· PL-100490880
Vyvgart
A efgartigimod alfa product containing efgartigimod alfa, registered in Poland by argenx BV. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Efgartigimod alfa is registered in 4 of 19 countries.
Countries holding a registration under ATC L04AA58 (efgartigimod alfa), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Efgartigimod alfa · ATC L04AA58
4 / 19 countries
- Belgiumprice
- Canada
- Ireland
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Efgartigimod alfa
- Manufacturer
- argenx BV
- Country
- Poland (PL)
- ATC code
- L04AA58
- ATC class
- Efgartigimod alfa
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Efgartigimod alfa in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVYVGARTargenx BV, Gent
- SwedenVyvgart 1000 mg Injektionsvätska, lösningArgenx
- BelgiumVyvgart 1000 mgArgenx
- IcelandVyvgartArgenx BV
- SwitzerlandVyvgart 1000 mg/ 5 ml, solution injectable en seringue préremplieargenx Switzerland SA
- FranceVYVGART 1 000 mg, solution injectable en seringue préremplieARGENX (BELGIQUE)
- SpainVYVGART 1.000 MG SOLUCION INYECTABLEArgenx B.V.
- FinlandVyvgartArgenx
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyvgart
- Liechtenstein · Vyvgart
- Norway · Vyvgart
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/97a86d33-6000-4bd9-aad6-696eafde6033 GET /v1/drugs/97a86d33-6000-4bd9-aad6-696eafde6033?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "1000 mg",
"packaging": "Rpz ¦ EU/1/22/1674/002 ¦ 152332\n1 fiol. 5,6 ml",
"substance": "Efgartigimod alfa 1000 mg",
"common_name": "Efgartigimod alfa",
"pl_product_id": "100490880",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about efgartigimod alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.